Terms: = Lung cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Clinical Outcome
12 results:
1. Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
[TBL] [Abstract] [Full Text] [Related]
2. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
3. Pleomorphic Undifferentiated Uterine Sarcoma in a Young Patient Presenting With Elevated Beta-hCG and Rare Variants of Benign Leiomyoma: A Case Report and Review of the Literature.
Krishnan V; Sauthier P; Provencher D; Rahimi K
Int J Gynecol Pathol; 2020 Jul; 39(4):362-366. PubMed ID: 31033798
[TBL] [Abstract] [Full Text] [Related]
4. ERβ Sensitizes NSCLC to Chemotherapy by Regulating DNA Damage Response.
Nikolos F; Thomas C; Bado I; Gustafsson JÅ
Mol Cancer Res; 2018 Feb; 16(2):233-242. PubMed ID: 29117942
[TBL] [Abstract] [Full Text] [Related]
5. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
[TBL] [Abstract] [Full Text] [Related]
6. MRI, MDCT features, and clinical outcome of extremity leiomyosarcomas: experience in 47 patients.
Gordon RW; Tirumani SH; Kurra V; Shinagare AB; Jagannathan JP; Hornick JL; Ramaiya NH
Skeletal Radiol; 2014 May; 43(5):615-22. PubMed ID: 24496586
[TBL] [Abstract] [Full Text] [Related]
7. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
Jia C; Mei F; Zheng J; You JF; Liu JY
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
[TBL] [Abstract] [Full Text] [Related]
8. DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancer.
van Boerdonk RA; Sutedja TG; Snijders PJ; Reinen E; Wilting SM; van de Wiel MA; Thunnissen FE; Duin S; Kooi C; Ylstra B; Meijer CJ; Meijer GA; Grünberg K; Daniels JM; Postmus PE; Smit EF; Heideman DA
Am J Respir Crit Care Med; 2011 Oct; 184(8):948-56. PubMed ID: 21799074
[TBL] [Abstract] [Full Text] [Related]
9. clinical outcome of leiomyosarcomas of vascular origin: comparison with leiomyosarcomas of other origin.
Italiano A; Toulmonde M; Stoeckle E; Kind M; Kantor G; Coindre JM; Bui B
Ann Oncol; 2010 Sep; 21(9):1915-1921. PubMed ID: 20167595
[TBL] [Abstract] [Full Text] [Related]
10. clinical outcome of metastatic uterine leiomyosarcoma and carcinosarcoma in a single institute.
Yoshinaga M; Togami S; Tsuji T; Fukamachi N; Kamio M; Yanagi M; Douchi T
J Obstet Gynaecol Res; 2007 Dec; 33(6):818-22. PubMed ID: 18001448
[TBL] [Abstract] [Full Text] [Related]
11. Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma.
Shah L; Walter KL; Borczuk AC; Kawut SM; Sonett JR; Gorenstein LA; Ginsburg ME; Steinglass KM; Powell CA
Cancer; 2004 Oct; 101(7):1632-8. PubMed ID: 15378500
[TBL] [Abstract] [Full Text] [Related]
12. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins.
Plaat BE; Hollema H; Molenaar WM; Torn Broers GH; Pijpe J; Mastik MF; Hoekstra HJ; van den Berg E; Scheper RJ; van der Graaf WT
J Clin Oncol; 2000 Sep; 18(18):3211-20. PubMed ID: 10986053
[TBL] [Abstract] [Full Text] [Related]